» Articles » PMID: 24581290

Current Ideas to Reduce or Salvage Radiation Damage to Salivary Glands

Overview
Journal Oral Dis
Specialty Dentistry
Date 2014 Mar 4
PMID 24581290
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation-induced hyposalivation is still a major problem after radiotherapy for head and neck cancer. Current and promising new thoughts to reduce or salvage radiation damage to salivary gland tissue are explored. The main cause underlying radiation-induced hyposalivation is a lack of functional saliva-producing acinar cells resulting from radiation-induced stem cell sterilization. Current methods to prevent that damage are radiation techniques to reduce radiation-injury to salivary gland tissue, surgical techniques to relocate salivary glands to a region receiving a lower cumulative radiation dose, and techniques to make salivary gland cells more resistant to radiation injury. These preventive techniques cannot be applied in all cases, also reduce tumor sensitivity, or do not result in a sufficient amelioration of the dryness-related complaints. Therefore, alternative methods on techniques to salvage salivary glands that are damaged by radiation are explored with promising results, such as stem cell therapies and gene transfer techniques to allow the radiation-injured salivary gland tissue to secrete water.

Citing Articles

Three-Dimensional Deep Learning Normal Tissue Complication Probability Model to Predict Late Xerostomia in Patients With Head and Neck Cancer.

Chu H, de Vette S, Neh H, Sijtsema N, Steenbakkers R, Moreno A Int J Radiat Oncol Biol Phys. 2024; 121(1):269-280.

PMID: 39147208 PMC: 11646177. DOI: 10.1016/j.ijrobp.2024.07.2334.


Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies.

Starska-Kowarska K Cells. 2024; 13(15.

PMID: 39120301 PMC: 11311692. DOI: 10.3390/cells13151270.


Examining patient-reported late toxicity and its association with quality of life and unmet need for symptom management among nasopharyngeal cancer survivors: a cross-sectional survey.

Tam V, Ching J, Yip S, Kwong V, Chan C, Wong K Front Oncol. 2024; 14:1378973.

PMID: 38694788 PMC: 11061844. DOI: 10.3389/fonc.2024.1378973.


Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer.

van Zanten J, Jorritsma-Smit A, Westra H, Baanstra M, Bruin-Jellema A, Allersma D Pharmaceutics. 2024; 16(3).

PMID: 38543329 PMC: 10976128. DOI: 10.3390/pharmaceutics16030435.


Mesenchymal Stromal/Stem Cell Therapy Improves Salivary Flow Rate in Radiation-Induced Salivary Gland Hypofunction in Preclinical in vivo Models: A Systematic Review and Meta-Analysis.

Fenger Carlander A, Gundestrup A, Jansson P, Follin B, Hoeeg C, Kousholt B Stem Cell Rev Rep. 2024; 20(4):1078-1092.

PMID: 38430363 PMC: 11087340. DOI: 10.1007/s12015-024-10700-y.